CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2013

View the entire original 990 at ProPublica ↗

Organization: CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 31-1667995)
Tax period: 2013-01-01 to 2013-12-31
Filed: 2014-08-08
IRS object ID: 201412209349300206
Schema version: 2013v3.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule I
Schedule J
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2014-08-08T07:51:24-05:00	ReturnTs
Tax Period End	2013-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	521855942	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	TATE AND TRYON	BusinessNameLine1

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	2021 L STREET NW SUITE 400	AddressLine1
City	WASHINGTON	City
State	DC	State
ZIP Code	20036	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2013-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	311667995	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF THE	BusinessNameLine1
Business Name Line2	AMERICAN SOCIETY OF CLINICAL ONCOLOGY	BusinessNameLine2

Field	Value	IRS element (for citing)
Business Name Control	CONQ	BusinessNameControlTxt
Phone	5714831700	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	PAUL AINES	PersonNm
Person Title	CFO	PersonTitleTxt
Phone	5714831300	PhoneNum
Signature	2014-08-08	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEBORAH G KOSNETT	PreparerPersonNm
PTIN	P00290720	PTIN
Phone	2022932200	PhoneNum

Field	Value	IRS element (for citing)
Tax	2013	TaxYr
Build TS	2015-11-30 17:44:51Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	ALLEN LICHTER MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	$44,743,488	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.CONQUERCANCERFOUNDATION.ORG	WebsiteAddressTxt
Type Of Organization Trust	Yes (X)	TypeOfOrganizationTrustInd
Formation	1999	FormationYr
Legal Domicile State	VA	LegalDomicileStateCd
Activity Or Mission	CCF'S VISION IS A WORLD FREE FROM THE FEAR OF CANCER. THE MISSION STATEMENT FOR CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) IS: CONQUERING CANCER WORLDWIDE BY FUNDING BREAKTHROUGH RESEARCH AND SHARING CUTTING-EDGE KNOWLEDGE.	ActivityOrMissionDesc
Voting Members Governing Body	14	VotingMembersGoverningBodyCnt
Voting Members Independent	13	VotingMembersIndependentCnt
Total Employee	0	TotalEmployeeCnt
Total Volunteers	109	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$25,403,476	PYContributionsGrantsAmt
CY Contributions Grants	$22,671,350	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$0	CYProgramServiceRevenueAmt
PY Investment Income	$1,387,836	PYInvestmentIncomeAmt
CY Investment Income	$1,907,790	CYInvestmentIncomeAmt
PY Other Revenue	$0	PYOtherRevenueAmt
CY Other Revenue	$0	CYOtherRevenueAmt
PY Total Revenue	$26,791,312	PYTotalRevenueAmt
CY Total Revenue	$24,579,140	CYTotalRevenueAmt
PY Grants And Similar Paid	$16,299,020	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$13,796,349	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$0	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$0	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$110,025	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$1,886,856	CYTotalFundraisingExpenseAmt
PY Other Expenses	$4,338,161	PYOtherExpensesAmt
CY Other Expenses	$4,646,888	CYOtherExpensesAmt
PY Total Expenses	$20,747,206	PYTotalExpensesAmt
CY Total Expenses	$18,443,237	CYTotalExpensesAmt
PY Revenues Less Expenses	$6,044,106	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$6,135,903	CYRevenuesLessExpensesAmt
Total Assets BOY	$43,383,551	TotalAssetsBOYAmt
Total Assets EOY	$47,043,311	TotalAssetsEOYAmt
Total Liabilities BOY	$8,230,445	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$5,004,208	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$35,153,106	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$42,039,103	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) WAS STARTED BY CANCER DOCTORS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), TO FIGHT AND CONQUER ALL TYPES OF CANCER WORLDWIDE. CCF SEEKS DRAMATIC ADVANCES IN THE PREVENTION, TREATMENT AND CURE OF CANCER - ALL TYPES OF CANCER - WHEREVER THEY OCCUR BY FUNDING BREAKTHROUGH RESEARCH, PATIENT INFORMATION, PROFESSIONAL EDUCATION, AND QUALITY IMPROVEMENT PROGRAMS. CCF DISTINGUISHES ITSELF THROUGH ITS UNMATCHED REACH AND EXPERTISE. WE FOCUS ON EVERY MOMENT THAT CANCER TOUCHES PEOPLE'S LIVES, FROM PREVENTION TO END-OF-LIFE CARE, AND WE ADDRESS NEARLY EVERY CANCER TYPE, INCLUDING RARE FORMS. CCF DRAWS ON THE EXPERTISE OF THE GLOBAL NETWORK OF ASCO, WITH MORE THAN 35,000 ONCOLOGY PROFESSIONAL MEMBERS WHO TREAT PATIENTS WITH CANCER EVERY DAY AND LEAD THE SEARCH FOR NEW CURES. CCF'S PROGRAMS ARE GLOBAL IN SCOPE AND HAVE AN IMPACT ON EVERY PATIENT WHO SEES AN ONCOLOGIST.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$9,129,895	ExpenseAmt
Grant	$8,294,955	GrantAmt
Desc	PROFESSIONAL EDUCATION - WE HELP ONCOLOGISTS WORLDWIDE STAY UP TO DATE ON THE LATEST DEVELOPMENTS AND DISCOVERIES IN CANCER KNOWLEDGE. CCF SUPPORTS THE EFFORTS OF ASCO TO PROVIDE THE LATEST KNOWLEDGE AND PROVIDE EDUCATION TO PHYSICIANS, RESEARCHERS AND CAREGIVERS AROUND THE WORLD. THIS WORK PROVIDES A DIRECT IMPACT AND BENEFIT TO EVERY CANCER PATIENT IN THE U.S. AND AROUND THE WORLD. FUNDS FROM CCF ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THAT PROVIDE THE LATEST DATA TO CANCER DOCTORS AND OTHER HEALTHCARE PROFESSIONALS WORLDWIDE THROUGH BOTH LIVE MEETINGS AND PRINT AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC MEETINGS SUPPORTED BY CCF AND PRESENTED TO THE PUBLIC IN 2013 INCLUDE THE FOLLOWING:* THE ASCO ANNUAL MEETING FEATURED MORE THAN 250 EDUCATIONAL AND SCIENTIFIC SESSIONS. OVER 4,700 ABSTRACTS WERE PRESENTED OR PUBLISHED. THE ASCO ANNUAL MEETING IS CONSIDERED THE PREMIER EDUCATIONAL AND SCIENTIFIC EVENT IN THE ONCOLOGY COMMUNITY AND ATTRACTS MORE THAN 32,000 ATTENDEES WORLDWIDE. THE MEETING IS DESIGNED TO ADVANCE THE EDUCATION OF PHYSICIANS AND OTHER PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE, TO SUPPORT THE DEVELOPMENT OF CLINICAL CANCER RESEARCHERS AND TO FACILITATE THE DELIVERY OF HIGH-QUALITY HEALTH CARE TO PATIENTS WITH CANCER. SCIENTIFIC AND EDUCATIONAL SESSIONS ARE DESIGNED TO PROVIDE MEETING ATTENDEES OPTIMUM LEARNING EXPERIENCES THROUGH DISEASE-SPECIFIC TOPICS AND ONCOLOGY-RELATED SUBJECTS.* QUALITY CARE SYMPOSIUM IS A TWO-DAY NATIONAL SYMPOSIUM FOCUSING ON INNOVATIVE STRATEGIES TO ADVANCE THE AREAS OF QUALITY MEASUREMENT, QUALITY IMPROVEMENT, PATIENT OUTCOMES, COMPARATIVE EFFECTIVENESS RESEARCH AND THE ELIMINATION OF DISPARITIES IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER IN THE UNITED STATES. THE OVERARCHING GOAL IS TO IMPROVE THE HEALTH OF ALL INDIVIDUALS WITH CANCER, THOSE AT INCREASED RISK OF DEVELOPING CANCER, AND CANCER SURVIVORS.* GASTROINTESTINAL CANCERS (GI) SYMPOSIUM - THE ANNUAL GI SYMPOSIUM IS THE PREMIERE MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING OFFERING THE MOST UP-TO-DATE STRATEGIES IN PREVENTION, SCREENING, AND TREATMENT OF GASTROINTESTINAL CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE, ASCO, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF SURGICAL ONCOLOGY.* GENITOURINARY CANCERS (GU) SYMPOSIUM - THE ANNUAL GU SYMPOSIUM IS THE PREEMINENT GENITOURINARY CANCER SCIENTIFIC AND EDUCATIONAL MEETING PROVIDING THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY ASCO, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF UROLOGIC ONCOLOGY.* BREAST CANCER (BCS) SYMPOSIUM - THE ANNUAL BREAST CANCER SYMPOSIUM FEATURES PRESENTATIONS ON THE LATEST MULTIDISCIPLINARY RESEARCH FROM SELECTED THEME-BASED TRANSLATIONAL AND CLINICAL ABSTRACTS, AS WELL AS RELATED EDUCATIONAL SESSIONS. THIS SYMPOSIUM OFFERS AN OPPORTUNITY FOR CLINICALLY RELEVANT, IN-DEPTH DISCUSSIONS OF HOW AND WHEN TO TRANSLATE NEW FINDINGS INTO PATIENT CARE ULTIMATELY TO IMPROVE OUTCOMES FOR PATIENTS REQUIRING BREAST CANCER THERAPY. THE MEETING IS JOINTLY DEVELOPED BY ASCO, THE AMERICAN SOCIETY OF BREAST DISEASE, THE AMERICAN SOCIETY OF BREAST SURGEONS, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, THE NATIONAL CONSORTIUM OF BREAST CENTERS, INC., THE SOCIETY OF SURGICAL ONCOLOGY. * BEST OF ASCO HELD IN CHICAGO, IL, BOSTON, MA, AND LOS ANGELES, CA- THE BEST OF ASCO MEETING PROGRAM CONDENSES HIGHLIGHTS FROM THE ASCO ANNUAL MEETING INTO A TWO DAY EDUCATIONAL MEETING, WHICH PROVIDES A UNIQUE, INTIMATE FORUM FOR THE PRESENTATION AND DISCUSSION OF THE PRACTICE-CHANGING SCIENCE AND EDUCATIONAL HIGHLIGHTS THAT WERE PRESENTED. A PANEL OF ASCO EXPERTS SELECTS ABSTRACTS THAT HIGHLIGHT THE IMPORTANT SCIENTIFIC INFORMATION TO CREATE THE BEST OF ASCO MEETING PROGRAM. THIS PROGRAM PROVIDES ACCESS TO THE MOST CUTTING-EDGE, PRACTICE-CHANGING RESEARCH PRESENTED AT THE MEETING IN A RESPONSIBLE, PEER-REVIEWED MANNER.* ASCO/AACR METHODS WORKSHOP - THIS INTENSIVE ANNUAL WORKSHOP, IN PARTNERSHIP WITH THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, BRINGS TOGETHER CLINICAL FELLOWS AND JUNIOR FACULTY CLINICAL RESEARCHERS IN ALL CANCER TYPES. THE WORKSHOP TEACHES ATTENDEES HOW TO PLAN AND CONDUCT AN EFFECTIVE CLINICAL TRIAL. THE OVERALL GOAL OF THE WORKSHOP IS TO INCREASE THE RELIABILITY AND EFFECTIVENESS OF CLINICAL TRIALS ULTIMATELY LEADING TO BETTER PATIENT CARE.HIGHLIGHTS OF PRINT AND ELECTRONIC PROFESSIONAL EDUCATION MATERIALS SUPPORTED BY CCF AND AVAILABLE TO THE PUBLIC IN 2013 INCLUDE THE FOLLOWING:PROCEEDINGS - THE PROCEEDINGS PUBLICATIONS FOR THE ASCO ANNUAL MEETING AND SELECT COSPONSORED THEMATIC SYMPOSIA CONTAIN ALL THE ABSTRACTS SELECTED FOR PRESENTATION AT THE LIVE EDUCATIONAL MEETING AND ALLOWS THOSE NOT ABLE TO ATTEND ACCESS TO THE GROUND-BREAKING ABSTRACTS THAT WERE PRESENTED.EDUCATIONAL BOOKS -THE ASCO ANNUAL MEETING EDUCATIONAL BOOK IS THE COMPREHENSIVE RESOURCE FOR EDUCATION SESSION MATERIALS FROM THE ASCO ANNUAL MEETING, ALLOWING THE ENTIRE ONCOLOGY COMMUNITY TO BENEFIT FROM DISCUSSIONS OF CRITICAL RESEARCH UPDATES IN A POINT-OF-CARE CONTEXT. MANUSCRIPTS DISCUSS THE CURRENT STANDARDS OF CARE AND EXISTING TECHNOLOGIES BUT ALSO LOOK TOWARD THE FUTURE, DISCUSSING RESEARCH IMPROVEMENTS AND TRENDS AND TREATMENTS STILL ON THE HORIZON.ABSTRACTS ON ASCO.ORG - ABSTRACTS ON ASCO.ORG PROVIDE THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. THE ABSTRACTS ON ASCO.ORG COMPRISE ASCO'S COMPREHENSIVE ONLINE DATABASE OF ONCOLOGY-RELATED RESEARCH ABSTRACTS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1995.VIRTUAL MEETINGS ON ASCO.ORG - THE VIRTUAL MEETINGS WEBSITE USES THE LATEST TECHNOLOGY TO PROVIDE THE RESULTS OF THE LATEST CANCER SCIENTIFIC AND EDUCATION INFORMATION TO HEALTHCARE PROFESSIONALS INVOLVED IN CANCER CARE. EACH SESSION INCLUDED ON THE VIRTUAL MEETINGS HAS ITS OWN OBJECTIVES. VIRTUAL MEETINGS USES THE LATEST TECHNOLOGY TO ALLOW USERS TO VIEW AND REVIEW SESSIONS THE VIRTUAL MEETING FEATURES MORE THAN 25,000 ORAL PRESENTATIONS, ABSTRACTS, AND POSTERS FROM THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC SYMPOSIA DATING BACK FIVE YEARS - THE MOST COMPREHENSIVE COLLECTION OF ONCOLOGY-RELATED MULTIMEDIA (SLIDES AND AUDIO) LECTURES AVAILABLE ONLINE.ONLINE PORTALS - ASCO WEBSITES PLAY AN IMPORTANT ROLE IN EDUCATING ASCO MEMBERS AS WELL AS THE BROADER CANCER CARE COMMUNITY. ASCO'S DISEASE-SPECIFIC "CANCER PORTALS" ARE ORGANIZED THEMATICALLY FOR EASY ACCESS AND USAGE, ARE ACCESSIBLE FROM THE ASCO.ORG HOMEPAGE, A DIRECT URL, OTHER AREAS OF THE WEBSITE AND FROM SEARCH QUERY RESULTS. THE CANCER PORTALS ARE THE PRODUCT OF A COLLABORATION BETWEEN ASCO, THE JOURNAL OF CLINICAL ONCOLOGY (JCO), THE JOURNAL OF ONCOLOGY PRACTICE (JOP) AND HIGHWIRE PRESS-AN E-PUBLISHING DIVISION OF THE STANFORD UNIVERSITY LIBRARIES, WHICH PRODUCES ONLINE VERSIONS OF PEER-REVIEWED JOURNALS AND SCHOLARLY CONTENT. THE INFORMATION GENERATED FROM ASCO'S FAMILY OF WEBSITES TO THE CANCER PORTALS IS TRANSFERRED SEAMLESSLY TO USERS IN AN EASY-TO-BROWSE FORMAT.ASCO UNIVERSITY - ASCO UNIVERSITY IS AN ONLINE PLATFORM THAT PROVIDES EDUCATION FOR ONCOLOGY PROFESSIONALS. COURSE CONTENT IS DEVELOPED AND PRESENTED BY RECOGNIZED EXPERTS. ASCO UNIVERSITY SERVES AS THE EDUCATIONAL HOME AND SOURCE FOR SELFDIRECTED LEARNING ACTIVITIES FOR PRACTICING ONCOLOGISTS AND THE NEXT GENERATION OF FELLOWS AND RESIDENTS. THE ACTIVITIES ON ASCO UNIVERSITY INCORPORATE FLEXIBLE, ROBUST CURRICULA WITH COLLATERAL PRODUCTS THAT TRANSLATE KEY ADULT LEARNING PRINCIPLES INTO INTERACTIVE EDUCATIONAL EXPERIENCES.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$6,343,170	ExpenseAmt
Grant	$5,172,487	GrantAmt
Desc	RESEARCH - IN THIS AGE OF SCIENTIFIC PROMISE, FEDERAL FUNDS FOR CANCER RESEARCH ARE DECLINING. FULFILLING THE PROMISE OF TODAY'S ADVANCES REQUIRES FUNDING FOR RESEARCH PROJECTS AND SUPPORT FOR INVESTIGATORS WHO WISH TO PURSUE A CAREER IN CLINICAL AND TRANSLATIONAL CANCER RESEARCH. WITHOUT CONTINUED, WELL-TARGETED RESEARCH, THERE WOULD BE NO MEANINGFUL PROGRESS. CCF PRIDES ITSELF ON ITS STANDARDS FOR SCIENTIFIC RIGOR, IMPLEMENTING A MULTISTAGE PEER REVIEW PROCESS WITH THE PARTICIPATION OF GLOBALLY RECOGNIZED SCIENTISTS, ONCOLOGISTS, AND BIOSTATISTICIANS IN THE SELECTION OF MERITORIOUS RESEARCH FOR FUNDING. SINCE 1984, CCF AND ASCO HAVE FUNDED MORE THAN $83 MILLION IN CANCER RESEARCH GRANTS TO NEARLY A THOUSAND RECIPIENTS. IN 2013, CCF AWARDED 60 RESEARCH GRANTS. CCF FUNDS THE ENTIRE SPECTRUM OF RESEARCH ACTIVITIES RELATED TO CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. EACH YEAR, CCF FUNDS AND AWARDS MULTIPLE RESEARCH GRANTS DESIGNED TO HELP ATTRACT AND RETAIN THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TO SUPPORT THEIR EFFORTS.HIGHLIGHTS OF 2013 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE:ADVANCED CLINICAL RESEARCH AWARD (ACRA)- $450,000 PROVIDED ONE (1) THREE-YEAR AWARD INTENDED TO FUND AN INVESTIGATOR COMMITTED TO CLINICAL CANCER RESEARCH AND WHO IS CONDUCTING ORIGINAL RESEARCH IN BREAST CANCER.CAREER DEVELOPMENT AWARD (CDA)- $1,800,000 PROVIDED NINE (9) THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENTS AND ARE ESTABLISHING INDEPENDENT CLINICAL CANCER RESEARCH PROGRAMS.YOUNG INVESTIGATOR AWARD (YIA)- $2,400,000 PROVIDED FORTY- EIGHT (48) ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT.LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE)- $230,000 PROVIDED TWO (2) ONE-YEAR FELLOWSHIPS TO EARLY-CAREER ONCOLOGISTS FROM LOW TO MIDDLE INCOME COUNTRIES FOR THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIPS WITH UNITED STATES OR CANADIAN COLLEAGUES AND THEIR U.S. OR CANADIAN INSTITUTIONS.GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP- $50,000 PROVIDED A ONE-YEAR FELLOWSHIP THAT ENABLES AN EARLY-CAREER INVESTIGATOR TO UNDERTAKE A BREAST CANCER PROJECT UNDER THE MENTORSHIP OF THE GIANNI BONADONNA BREAST AWARD RECIPIENT.THE JAMES B. NACHMAN JUNIOR FACULTY AWARD IN PEDIATRIC ONCOLOGY WAS ESTABLISHED IN MEMORY OF JAMES B. NACHMAN, MD, AN INTERNATIONALLY RENOWNED PEDIATRIC CANCER EXPERT AND PEDIATRICS PROFESSOR. HE CHAIRED SEVERAL CHILDREN'S ONCOLOGY GROUP NATIONAL STUDY COMMITTEES AND WAS AN AUTHORITY IN THE MEDICAL MANAGEMENT OF CHILDHOOD CANCERS, ESPECIALLY LEUKEMIA AND LYMPHOMA. $3,000 PROVIDED FOR ONE JUNIOR FACULTY MEMBER WITH THE HIGHEST-SCORING ABSTRACT IN PEDIATRIC ONCOLOGY TO PRESENT THE ABSTRACT AT THE ASCO ANNUAL MEETING.CLINICAL TRIALS PARTICIPATION AWARD (CTPA)- $14,000 PROVIDED SEVEN (7) AWARDS THAT PUBLICLY HONOR HIGH-QUALITY, COMMUNITY-BASED ONCOLOGY PRACTICES AND INSTITUTIONS THAT ACTIVELY PARTICIPATE IN CLINICAL TRIALS RESEARCH. THIS PROGRAM IS DESIGNED TO ENCOURAGE ONCOLOGY PRACTICES THAT CURRENTLY PARTICIPATE IN CLINICAL TRIALS TO INCREASE THEIR ACCRUAL RATES IN ORDER TO SUPPORT CANCER RESEARCH AND ADVANCES.MERIT AWARDS- $176,000 PROVIDED FOR THE BRADLEY STUART BELLER MERIT AWARD AND 171 OTHER MERIT AWARDS, WHICH PROMOTE CLINICAL RESEARCH BY PROVIDING YOUNG SCIENTISTS WHOSE RESERACH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS AND DISEASE-SPECIFIC SYMPOSIA.ONCOLOGY TRAINEE TRAVEL AWARDS- $21,280 PROVIDED FOR NINETEEN (19) TRAVEL AWARDS TO ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS BY PROVIDING THEM INDIVIDUAL TRAVEL GRANTS TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING.CCF ALSO RAISED FUNDS FOR A NUMBER OF AWARDS PROVIDED BY ASCO IN ORDER TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS THAT HAVE MADE SIGNIFICANT CONTRIBUTIONS TO ASCO, THE PRACTICE OF CLINICAL ONCOLOGY, AND CANCER PATIENTS. HIGHLIGHTS OF AWARDS SUPPORTED BY THE FOUNDATION IN 2013 INCLUDED:GIANNI BONADONNA BREAST CANCER AWARD AND LECTURE- THIS AWARD RECOGNIZED AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER AS WELL AS EXCEPTIONAL MENTORING ABILITIES. THE AWARD WINNER GAVE A LECTURE DURING THE BREAST CANCER SYMPOSIUM.BJ KENNEDY AWARD AND LECTURE- THIS AWARD RECOGNIZED A GERIATRIC ONCOLOGIST WHO HAS DEMONSTRATED OUTSTANDING LEADERSHIP AND ACHIEVEMENT IN THE FIELD OF GERIATRIC ONCOLOGY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.AMERICAN CANCER SOCIETY AWARD AND LECTURE - THIS AWARD RECOGNIZED AN ONCOLOGIST THAT HAS MADE A SIGNIFICANT CONTRIBUTION TO CANCER PREVENTION AND CONTROL RESEARCH OR PRACTICE. THE AWARD IS JOINTLY SUPPORTED BY THE AMERICAN CANCER SOCIETY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$194,510	ExpenseAmt
Grant	$187,000	GrantAmt
Desc	QUALITY AND ACCESS TO CARE - REMARKABLE ADVANCES IN CANCER MEDICINE ARE OCCURRING MORE AND MORE FREQUENTLY, YET THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH-QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CCF IS KEENLY AWARE OF THE POTENTIALLY FATAL DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE AND THOSE WITHOUT. WE SEEK TO CONFRONT THESE DISPARITIES AND IMPROVE THE OUTLOOK FOR EVERY PERSON TOUCHED BY CANCER BY SUPPORTING PROGRAMS THAT INCREASE ACCESS TO CARE IN ALL COMMUNITIES, INCLUDING THOSE UNDERSERVED. THE QUALITY AND ACCESS TO CARE PROGRAMS AND INITIATIVES SUPPORTED BY CCF IN 2013 INCLUDE THE FOLLOWING:CANCERLINQ; THIS GROUND-BREAKING HEALTH INFORMATION TECHNOLOGY INITIATIVE WILL UNLOCK AND ANALYZE CANCER CARE DATA, FEEDING NEAR REAL-TIME CONCLUSIONS AND GUIDANCE BACK TO PHYSICIANS. CANCERLINQ WILL ACHIEVE HIGHER QUALITY, HIGHER-VALUE CANCER CARE WITH BETTER OUTCOMES FOR PATIENTS. THIS EFFORT IS INTENDED TO TRANSFORM THE WAY ONCOLOGISTS PRACTICE, LEARN, AND INTERACT WITH THEIR PATIENTS. STATE/REGIONAL AFFILIATE PROGRAM - THE ASCO STATE/REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ADDRESS ISSUES IN THE PRACTICE OF ONCOLOGY ON THE LOCAL LEVEL. THE PROGRAM INCLUDES FACILITATION OF INTERACTION AMONG ASCO AND 48 STATE OR REGIONAL ONCOLOGY SOCIETIES THAT HAVE ACCESS TO THE SOCIETY'S EXPERTISE AND GUIDANCE ON WAYS TO STRENGTHEN THEIR ORGANIZATIONS, ENHANCE THEIR EDUCATIONAL ACTIVITIES, AND PROVIDE ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL.DIVERSITY IN ONCOLOGY INITIATIVE - THE CCF GRANTS AND AWARDS PROGRAM PROVIDES FUNDING FOR DIFFERENT TYPES OF AWARD OPPORTUNITIES FOR ONCOLOGY FELLOWS, CLINICAL PRACTICES, ANDINTERNATIONAL RESEARCHERS. ONE OF THE PROGRAMS OFFERED THROUGH CCF IS THE DIVERSITY IN ONCOLOGY INITIATIVE. THE DIVERSITY IN ONCOLOGY INITIATIVE WAS STRUCTURED TO FACILITATE THE RECRUITMENT AND RETENTION OF INDIVIDUALS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE TO CANCER CAREERS, WITH PARTICULAR ATTENTION TO THE DEVELOPMENT OF CLINICAL PRACTITIONERS AND INVESTIGATORS.IN 2013, $111,000 PROVIDED TWO PROGRAMS FOR INDIVIDUALS INTERESTED OR CURRENTLY PRACTICING IN THE ONCOLOGY FIELD:MEDICAL STUDENT ROTATION - THE MEDICAL STUDENT ROTATION (MSR), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. IN 2013, $102,000 PROVIDED 12 MSRS.RESIDENT TRAVEL AWARD - THE RESIDENT TRAVEL AWARD PROVIDES FINANCIAL SUPPORT FOR RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO ATTEND ASCO'S ANNUAL MEETING. THE INTENTION OF THIS AWARD IS TO ATTRACT RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO A POSSIBLE CAREER IN ONE OF THE ONCOLOGY SPECIALTIES. THIS TRAVEL AWARD WILL ALLOW THE RECIPIENTS TO TRAVEL TO THE ASCO ANNUAL MEETING, WHERE THEY WILL HAVE AN OPPORTUNITY TO MEET ONCOLOGISTS AND TO UNDERSTAND THE CAREER POSSIBILITIES IN THE AREA. IN 2013, $9,000 FUNDED 6 RTAS.ALTHOUGH A NUMBER OF PROGRAMS EXIST TO RECRUIT INDIVIDUALS UNDERREPRESENTED IN MEDICINE, FEW OF THESE PROGRAMS FOCUS SPECIFICALLY ON RECRUITMENT TO CLINICAL ONCOLOGY. ULTIMATELY, IT IS HOPED THAT INCREASING DIVERSITY IN THE CLINICAL ONCOLOGY PROFESSION WILL LEAD TO INCREASED AND IMPROVED CANCER CARE FOR UNDERSERVED POPULATIONS AS WELL AS INCREASED RESEARCH ON HEALTH DISPARITIES.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$337,610	ExpenseAmt
Grant	$141,907	GrantAmt
Desc	PATIENT EDUCATION AND INFORMATION - WELL-INFORMED, EDUCATED PATIENTS ARE THEIR OWN BEST ADVOCATES, AS WELL AS INVALUABLE PARTNERS FOR DOCTORS. CCF SUPPORTS PROGRAMS AND ACCURATE, DOCTOR-APPROVED CANCER INFORMATION AND RESOURCES BOTH IN PRINT AND ONLINE, THAT EDUCATE PATIENTS AND THE PUBLIC ABOUT CANCER CARE, TREATMENT, RESEARCH,PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. FUNDING IN THIS AREA ALLOWS CCF TO CONTINUE AND EXPAND OUR WORK TO INFORM PATIENTS.HIGHLIGHTS OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CCF IN 2013 INCLUDE THE FOLLOWING:PATIENT ADVOCATE SCHOLARSHIP PROGRAM- THE PATIENT ADVOCATE SCHOLARSHIP PROGRAM PROVIDES TRAVEL GRANTS TO A SELECT NUMBER OF PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS. IN 2013, $181,850 IN FUNDING ALLOWED 111 PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS.CANCER.NET- CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. THE WEBSITE PROVIDES TIMELY, COMPREHENSIVE INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS. ALL CONTENT IS SUBJECT TO A FORMAL PEER-REVIEW PROCESS BY THE CANCER.NET EDITORIAL BOARD, COMPOSED OF MORE THAN 150 MEDICAL, SURGICAL, RADIATION, AND PEDIATRIC ONCOLOGISTS, PHYSICIAN ASSISTANTS, ONCOLOGY NURSES, SOCIAL WORKERS, AND PATIENT ADVOCATES AND INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 124 TYPES OF CANCER AND SYNDROMES, INCLUDING RISK FACTORS, DIAGNOSIS, FINDING AN ONCOLOGIST, TREATMENT, MANAGING SIDE EFFECTS, CLINICAL TRIALS AFTER TREATMENT, CAREGIVING, COPING STRATEGIES, AND SURVIVORSHIP. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC. IN 2013, THERE WERE MORE THAN 7,000,000 VISITS AND MORE THAN 16,000,000 PAGE VIEWS OF CANCER.NET. CCF CONTINUES TO SUPPORT THE PRODUCTION OF ASCO'S PRINTED PATIENT INFORMATION MATERIALS, SUCH AS:ASCO ANSWERS FACT SHEETS- ASCO ANSWERS IS A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC. CURRENT DISEASE-SPECIFIC FACT SHEETS INCLUDE: BREAST, COLORECTAL, LUNG, AND PROSTATE CANCERS AND ARE ALSO AVAILABLE IN SPANISH. EACH FACT SHEET INCLUDES AN OVERVIEW OF THE SUBJECT, TERMS TO KNOW, AND QUESTIONS TO ASK THE DOCTOR.PATIENT GUIDES- PATIENT GUIDES ARE PRINTED BOOKLETS CONTAININGCOMPREHENSIVE CANCER INFORMATION; INCLUDING AN OVERVIEW OF SPECIFIC CANCER TYPES, SYMPTOMS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIALS, AND AFTER TREATMENT. ONCOLOGY PROFESSIONALS AND PATIENTS EXPLORE THESE CANCER-SPECIFIC BOOKLETS TOGETHER AFTER A DIAGNOSIS OF CANCER. THERE ARE BOOKLETS FOR THE FOUR MOST COMMON TYPES OF CANCER IN THE UNITED STATES: BREAST, COLORECTAL, LUNG, PROSTATE AND ARE AVAILABLE IN ENGLISH AND SPANISH.INTERNATIONAL PROGRAMS - ASCO AND THE CONQUER CANCER FOUNDATION SHARE AN INTERNATIONAL MISSION TO ENGAGE THE PHYSICIAN AND HEALTHCARE PROFESSIONAL COMMUNITY ON A GLOBAL SCALE TO IMPROVE CARE TO CANCER PATIENTS AND ENHANCE THE EXCHANGE OF KNOWLEDGE TO FACILITATE ADVANCES IN THE CARE OF PEOPLE WITH CANCER EVERYWHERE. CCF FUNDS SUPPORT INTERNATIONAL PROGRAMS INCLUDING EDUCATION, FELLOWSHIP AND GRANT OPPORTUNITIES TO ENABLE ONCOLOGISTS FROM OPPOSITE ENDS OF THE WORLD TO SHARE IDEAS AND BUILD LASTING COLLABORATIONS THAT CAN ENHANCE PATIENT CARE LOCALLY AND GLOBALLY. CCF SUPPORTS THESE PROGRAMS THROUGH ITS INTERNATIONAL PROGRAM MISSION AS WELL AS THROUGH CCF'S OTHER MISSION AREAS (RESEARCH, PROFESSIONAL EDUCATION, PATIENT EDUCATION ANDINFORMATION AND QUALITY AND ACCESS TO CARE).CCF FUNDS SPECIFICALLY SUPPORTING INTERNATIONAL ACTIVITIES INCLUDE THE FOLLOWING:INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, ASSIST IN CAREER DEVELOPMENT AND HELP TO ESTABLISH STRONG RELATIONSHIPS WITH LEADING ASCO MEMBERS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT.ADVANCED CANCER COURSES (ACC)-THE ADVANCED CANCER COURSES ARE CAREFULLY DESIGNED TO FILL THE NEED FOR ADVANCED LEARNING FOR INTERNATIONAL ONCOLOGISTS. THESE COURSES CAN BE CHOSEN FROM ASCO'S PORTFOLIO OF EDUCATIONAL PRODUCTS, OR DEVELOPED WITH THE COLLABORATION OF VOLUNTEER ONCOLOGISTS.MULTIDISCIPLINARY CANCER MANAGEMENT COURSES- MANY PATIENTS WITH CANCER AROUND THE WORLD SUFFER FROM LACK OF ACCESS TO CANCER SPECIALISTS. THIS NEED IS ACUTE IN LOW-TO-MIDDLE INCOME COUNTRIES WHERE LACK OF RESOURCES RESULT IN LARGE PATIENT LOADS, STRETCHED FACILITIES AND INADEQUATE SUPPORT FOR ONCOLOGISTS. ASCO INTERNATIONAL'S MULTIDISCIPLINARY CANCER MANAGEMENT COURSES (MCMCS) TEACH THE VALUE OF INTERDISCIPLINARY MANAGEMENT OF CANCER TO ACHIEVE OPTIMAL OUTCOMES FOR PATIENTS. THE COURSES PROVIDE FUNDAMENTAL TRAINING FOR PHYSICIANS, NURSES, PATHOLOGISTS AND RESIDENTS IN COUNTRIES WHERE PATIENTS WITH CANCER ARE FREQUENTLY SEEN BY NON-SPECIALISTS. MCMCS TEACH MULTIDISCIPLINARY MANAGEMENT OF THE MOST PREVALENT CANCER TYPES IN THE HOST COUNTRY AND CENTER THE LEARNING ON PATIENTS. CONTENT AND TOPICS ARE TAILORED BASED ON THE NEEDS AND INTEREST OF EACH AUDIENCE AND CAN INCLUDE BREAST, COLON, ANAL CANAL, RECTAL, LUNG, PROSTATE AND HEAD AND NECK CANCERS, AMONG OTHERS. SINCE 2004, NEARLY 3,000 CLINICIANS AND HEALTH CARE WORKERS HAVE PARTICIPATED IN THESE COURSES. IN OVERALL COURSE EVALUATIONS, 70% OF PARTICIPANTS HAVE REPORTED CHANGING PRACTICE AND 87% OF PARTICIPANTS ARE MORE CONFIDENT IN THEIR CARE OF PATIENTS.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$337,610	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$141,907	TotalOtherProgSrvcGrantAmt
Total Program Service Expenses	$16,005,185	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	0	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Temp Or Permanent Endowments	Yes (1)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	0	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (1)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	0	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	Yes (1)	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	Yes (1)	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	0	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	0	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	147	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	0	EmployeeCnt
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	0	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (1)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (1)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	14	GoverningBodyVotingMembersCnt
Independent Voting Member	13	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	Yes (1)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (1)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	PAUL AINES CFO	PersonNm
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	SAME AS C ABOVE	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Form990 Part VII Section A Form990PartVIISectionAGrp (17 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt
W CHARLES PENLEY MD FASCO
CHAIR	1.00	1.00	Yes (X)	Yes (X)	$0	$0	$0
GABRIEL N HORTOBAGYI MDFACPFASCO
TREASURER	1.00		Yes (X)	Yes (X)	$0	$0	$0
JOHN H GLICK MD FASCO
SECRETARY	1.00		Yes (X)	Yes (X)	$0	$0	$0
ALLEN S LICHTER MD FASCO
CEO	4.00	33.50	Yes (X)	Yes (X)	$0	$784,820	$19,955
NANCY DALY MS MPH
EXECUTIVE DIRECTOR	37.50		Yes (X)	Yes (X)	$0	$231,000	$28,773
CLIFFORD HUDIS MD FACP
ASCO PRESIDENT	1.00	1.00	Yes (X)		$0	$0	$0
LAWRENCE H EINHORN MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
IRA M ELEGANT ESQ
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
MARTIN MURPHY DMEDSC PHD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
MICHAEL GORDON JD
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
STEVEN ROSEN MD FACP
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
SANDRA SWAIN MD FACP
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
BETH Y KARLAN MD
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
THOMAS A MARSLAND MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
ROBERT J MAYER MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
THOMAS G ROBERTS JR MD
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
PAUL AINES CPA
CFO	4.00	33.50		Yes (X)	$0	$317,000	$35,301

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$0	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$1,332,820	TotReportableCompRltdOrgAmt
Total Other Compensation	$84,029	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	0	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K	0	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$9,302	FederatedCampaignsAmt
Related Organizations	$2,339,996	RelatedOrganizationsAmt
All Other Contributions	$20,322,052	AllOtherContributionsAmt
Noncash Contributions	$4,984	NoncashContributionsAmt
Total Contributions	$22,671,350	TotalContributionsAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$927,925	TotalRevenueColumnAmt
Exclusion	$927,925	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$21,144,213	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$20,164,348	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$979,865	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$979,865	TotalRevenueColumnAmt
Exclusion	$979,865	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$24,579,140	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$1,907,790	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$13,303,709	TotalAmt
Program Services	$13,303,709	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$314,780	TotalAmt
Program Services	$314,780	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$177,860	TotalAmt
Program Services	$177,860	ProgramServicesAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$3,085,127	TotalAmt
Program Services	$1,675,326	ProgramServicesAmt
Management And General	$292,037	ManagementAndGeneralAmt
Fundraising	$1,117,764	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$22,455	TotalAmt
Management And General	$22,455	ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$177,588	TotalAmt
Management And General	$177,588	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$229,240	TotalAmt
Management And General	$108,930	ManagementAndGeneralAmt
Fundraising	$120,310	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$66,459	TotalAmt
Management And General	$60,049	ManagementAndGeneralAmt
Fundraising	$6,410	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$125,329	TotalAmt
Program Services	$81	ProgramServicesAmt
Management And General	$7,275	ManagementAndGeneralAmt
Fundraising	$117,973	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$295,032	TotalAmt
Management And General	$295,032	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$294,051	TotalAmt
Program Services	$55,883	ProgramServicesAmt
Management And General	$165,490	ManagementAndGeneralAmt
Fundraising	$72,678	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$154,922	TotalAmt
Program Services	$8,110	ProgramServicesAmt
Management And General	$84,081	ManagementAndGeneralAmt
Fundraising	$62,731	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
POSTAGE	$116,649	$1,490	$39,776	$75,383
DUES & SUBSCRIPTIONS	$55,834		$54,437	$1,397
BANK & CREDIT CARD FEES	$24,202		$24,202
ALLOCATION OF ADMINISTR	$0	$467,946	-$780,156	$312,210

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$18,443,237	TotalAmt
Program Services	$16,005,185	ProgramServicesAmt
Management And General	$551,196	ManagementAndGeneralAmt
Fundraising	$1,886,856	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$1,688,633	BOYAmt
EOY	$3,786,795	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$818,610	BOYAmt
EOY	$950,756	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$8,963,175	BOYAmt
EOY	$8,054,407	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$47,886	BOYAmt
EOY	$48,136	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$31,865,247	BOYAmt
EOY	$34,203,217	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$43,383,551	BOYAmt
EOY	$47,043,311	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$4,825,295	BOYAmt
EOY	$3,804,205	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$1,027,475	BOYAmt
EOY	$686,647	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$2,377,675	BOYAmt
EOY	$513,356	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$8,230,445	BOYAmt
EOY	$5,004,208	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$23,413,565	BOYAmt
EOY	$28,184,088	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$9,135,100	BOYAmt
EOY	$9,930,574	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$2,604,441	BOYAmt
EOY	$3,924,441	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$35,153,106	BOYAmt
EOY	$42,039,103	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$43,383,551	BOYAmt
EOY	$47,043,311	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$6,135,903	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$498,041	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$252,053	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consol And Sep Basis Fincl Stmt	Yes (X)	ConsolAndSepBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$24,169,849	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$24,400,007	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$23,206,830	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$25,403,476	CurrentTaxYearMinus1YearAmt
Current Tax Year	$24,662,684	CurrentTaxYearAmt
Total	$121,842,846	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$24,169,849	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$24,400,007	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$23,206,830	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$25,403,476	CurrentTaxYearMinus1YearAmt
Current Tax Year	$24,662,684	CurrentTaxYearAmt
Total	$121,842,846	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$39,025,516	SubstantialContributorsTotAmt
Public Support Total170	$82,817,330	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$195,182	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$136,059	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$595,807	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$925,158	CurrentTaxYearMinus1YearAmt
Current Tax Year	$927,924	CurrentTaxYearAmt
Total	$2,780,130	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$124,622,976	TotalSupportAmt
Public Support CY170	0.66450	PublicSupportCY170Pct
Public Support PY170	0.61030	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$2,605,326	BeginningYearBalanceAmt
Contributions	$1,320,000	ContributionsAmt
Investment Earnings Or Losses	$107,969	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,200	GrantsOrScholarshipsAmt
End Year Balance	$4,031,095	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$82,699	BeginningYearBalanceAmt
Contributions	$2,517,200	ContributionsAmt
Investment Earnings Or Losses	$7,627	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,200	GrantsOrScholarshipsAmt
End Year Balance	$2,605,326	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$82,241	BeginningYearBalanceAmt
Contributions	$5,000	ContributionsAmt
Investment Earnings Or Losses	-$2,594	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$1,948	GrantsOrScholarshipsAmt
End Year Balance	$82,699	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$116,963	BeginningYearBalanceAmt
Contributions	$15,930	ContributionsAmt
Investment Earnings Or Losses	$1,348	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$52,000	GrantsOrScholarshipsAmt
End Year Balance	$82,241	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$103,356	BeginningYearBalanceAmt
Contributions	$14,492	ContributionsAmt
Investment Earnings Or Losses	$1,115	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,000	GrantsOrScholarshipsAmt
End Year Balance	$116,963	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	1.00000	PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd
Total Book Value Land Buildings	$0	TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	DUE TO RELATED ORGANIZATION	Desc
Amt	$513,356	Amt

Field	Value	IRS element (for citing)
Total Liability	$513,356	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$24,899,593	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$498,041	NetUnrealizedGainsInvstAmt
Revenue Not Reported	$498,041	RevenueNotReportedAmt
Revenue Subtotal	$24,401,552	RevenueSubtotalAmt
Investment Expenses Not Incld	$177,588	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$177,588	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$24,579,140	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$18,013,596	TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included	-$252,053	OtherExpensesIncludedAmt
Expenses Not Reported	-$252,053	ExpensesNotReportedAmt
Expenses Subtotal	$18,265,649	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$177,588	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$177,588	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$18,443,237	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART V, LINE 4:	PERMANENTLY RESTRICTED NET ASSETS OF DONOR-RESTRICTED ENDOWMENT FUNDS ARE PRESERVED, ABSENT EXPLICIT DIRECTION FROM THE DONOR. INTEREST FROM THE PERMANENTLY RESTRICTED FUNDS IS INTENDED TO FUND FUTURE RESEARCH AND/OR EDUCATIONAL AWARDS. PART V, LINE 1A-1G: ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS.
PART X, LINE 2:	THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2010 THROUGH 2013 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES.
PART XII, LINE 2D - OTHER ADJUSTMENTS:	RELINQUISHED AWARDS -252,053.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
SOUTH AMERICA	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S)	MERIT AWARD ($1,000), INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD ($1,100)	$2,100
MIDDLE EAST AND NORTH AFRICA	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S)	MERIT AWARD ($1,000), INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD ($5,560)	$6,560
SOUTH ASIA	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S)	MERIT AWARD ($1,000), INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD ($5,600)	$6,600
SUB-SAHARAN AFRICA	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S)	INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD ($4,800)	$4,800

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continutation Total Office	0	ContinutationTotalOfficeCnt
Continutation Total Employee	0	ContinutationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$20,060	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$20,060	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
NORTH AMERICA	YOUNG INVESTIGATOR AWARD (YIA)	$50,000	CASH/CHECK
NORTH AMERICA	YOUNG INVESTIGATOR AWARD (YIA)	$50,000	CASH/CHECK

Field	Value	IRS element (for citing)
Total Other Org	2	TotalOtherOrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (8 entries)

Type Of AssistanceTypeOfAssistanceTxt	RegionRegionTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, QUALITY CARE SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	NORTH AMERICA	20	$20,200	CASH/CHECK
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	EUROPE	24	$25,700	CASH/CHECK
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	SOUTH AMERICA	2	$2,100	CASH/CHECK
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	EAST ASIA AND THE PACIFIC	10	$9,500	CASH/CHECK
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	MIDDLE EAST AND NORTH AFRICA	6	$6,560	CASH/CHECK
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	SOUTH ASIA	6	$6,600	CASH/CHECK
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	RUSSIA & THE NEWLY INDEPENDENT STATES	2	$2,400	CASH/CHECK
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	SUB-SAHARAN AFRICA	4	$4,800	CASH/CHECK

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (40 entries)

Address Line1USAddress/AddressLine1	CityUSAddress/City	StateUSAddress/State	ZIP CodeUSAddress/ZIPCode	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZA	HOUSTON	TX	77030	741613878	501 (C)(3)	$165,000	LONG-TERM INTERNATIONAL FELLOWSHIP, YOUNG INVESTIGATOR AWARD
CASE WESTERN RESERVE UNIVERSITY
11100 EUCLID AVE	CLEVELAND	OH	44106	341018992	501 (C)(3)	$115,000	LONG-TERM INTERNATIONAL FELLOWSHIP
DUKE UNIVERSITY MEDICAL CENTER
BOX 2714	DURHAM	NC	27710	560532129	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
DANA-FARBER CANCER INSTITUTE
44 BINNEY STREET BP431C	BOSTON	MA	02115	042263040	501 (C)(3)	$350,000	YOUNG INVESTIGATOR AWARDS
JOHNS HOPKINS UNIVERSITY
550 NORTH BROAKWAY SUITE 1003	BALTIMORE	MD	212052009	520591627	501 (C)(3)	$350,000	CAREER DEVELOPMENT AWARDS, YOUNG INVESTIGATOR AWARDS
MEMORIAL SLOAN-KETTERING CANCER CENTER
GENERAL POST OFFICE BOX 263633	NEW YORK	NY	10017	131924236	501 (C)(3)	$950,000	YOUNG INVESTIGATOR AWARDS, CAREER DEVELOPMENT AWARDS, GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP	THIRD AVE
SEATTLE CHILDRENS HOSPITAL
1100 OLIVE WAY	SEATTLE	WA	98101	910564748	501 (C)(3)	$200,000	CAREER DEVELOPMENT AWARDS
UNIVERSITY OF CALIFORNIA - SAN DIEGO
3855 HEALTH SCIENCE DRIVE	LA JOLLA	CA	92093	956006144	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 4486	HOUSTON	TX	77210	746000203	GOV'T UNIT	$200,000	YOUNG INVESTIGATOR AWARDS
UNC AT CHAPEL HILL
102 MASON FARM RD	CHAPEL HILL	NC	27599	566001393	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF PENNSYLVANIA
3400 SPRUCE ST	PHILADELPHIA	PA	19104	231352685	501 (C)(3)	$650,000	ADVANCED CLINICAL RESEARCH AWARDS, CAREER DEVELOPMENT AWARDS
(no name)
							YOUNG INVESTIGATOR AWARD
(no name)
							YOUNG INVESTIGATOR AWARDS
(no name)
							YOUNG INVESTIGATOR AWARD
YALE UNIVERSITY
333 CEDAR ST	NEW HAVEN	CT	06520	060646973	501 (C)(3)	$100,000	YOUNG INVESTIGATOR AWARD
MASSACHUSETTS GENERAL HOSPITAL
555 FRUIT STREET	BOSTON	MA	02114	041564655	501 (C)(3)	$150,000	YOUNG INVESTIGATOR AWARDS
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1802 SIXTH AVE SOUTH	BIRMINGHAM	AL	35294	636005396	GOV'T UNIT	$17,000	MEDICAL STUDENT ROTATION AWARDS
(no name)
							MEDICAL STUDENT ROTATION AWARD
AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2318 MILL RD 800	ALEXANDRIA	VA	22314	136180380	501 (C)(3)	$8,371,709	CONTRIBUTION
UNIVERSITY OF COLORADO DENVER
13001 E 17TH PLACE	AURORA	CO	80045	846000555	GOV'T UNIT	$450,000	CAREER DEVELOPMENT AWARDS, YOUNG INVESTIGATOR AWARD
ST JOSEPH'S HOSPITAL & MEDICAL CENTER
350 WEST THOMAS ROAD	PHOENIX	AZ	85013	860096787	501 (C)(3)	$200,000	CAREER DEVELOPMENT AWARD
UNIVERSITY OF WASHINGTON
1959 NE PACIFIC	SEATTLE	WA	98195	916001537	GOV'T UNIT	$200,000	CAREER DEVELOPMENT AWARD
COLUMBIA UNIVERSITY MEDICAL CENTER
630 WEST 168TH STREET	NEW YORK	NY	10032	135598093	501 (C)(3)	$108,500	YOUNG INVESTIGATOR AWARDS, MEDICAL STUDENT ROTATION AWARDS
UNIVERSITY OF MICHIGAN
1500 E MEDICAL CENTER DR	ANN ARBOR	MI	48109	386006309	GOV'T UNIT	$50,000	YOUNG INVESTIGATOR AWARD
H LEE MOFFITT CANCER CENTER UNIVERSITY OF SOUTH FLORIDA
12902 MAGNOLIA DR MCC-CEO	TAMPA	FL	336129497	592451713	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK ROAD	PORTLAND	OR	97239	931176109	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
BETH ISRAEL DEACONESS MEDICAL CENTER
330 BROOKLINE AVENUE	BOSTON	MA	02215	135564934	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH STREET AND CIVIC CENTER BLVD	PHILADELPHIA	PA	191044399	231352166	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
MEDSTAR HEALTH RESEARCH INSTITUTE
6525 BELCREST RD 700	HYATTSVILLE	MD	20782	526056274	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF CALIFORNIA - LOS ANGELES
10833 LE CONTE AVENUE	LOS ANGELES	CA	900951781	956006143	GOV'T UNIT	$50,000	YOUNG INVESTIGATOR AWARD
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVE N	SEATTLE	WA	98109	237156071	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREET	BOSTON	MA	02115	042312909	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
NEW YORK PRESBYTERIAN HOSPITAL
630 WEST 168TH STREET	NEW YORK	NY	10032	133957095	501 (C)(3)	$50,000	YOUNG INVESTIGATOR AWARD
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
10833 LE CONTE AVENUE	LOS ANGELES	CA	90095	954373071	GOV'T UNIT	$17,000	MEDICAL STUDENT ROTATION AWARDS
MAYO CLINIC MINNESOTA
200 FIRST ST SW	ROCHESTER	MN	55905	416011702	501 (C)(3)	$17,000	MEDICAL STUDENT ROTATION AWARDS
ROBERT WOOD JOHNSON MEDICAL SCHOOL UNIVERSITY OF MEDICINE AND DENTISTRY NJ
195 LITTLE ALBANY STREET	NEW BRUNSWICK	NJ	089032681	787958750	501 (C)(3)	$8,500	MEDICAL STUDENT ROTATION AWARDS
UNIVERSITY OF UTAH
2000 CIRCLE OF HOPE	SALT LAKE CITY	UT	841125550	876000525	GOV'T UNIT	$8,500	MEDICAL STUDENT ROTATION AWARDS
COOPER MEDICAL SCHOOL OF ROWAN UNIVERSITY CAMDEN NJ
401 BROADWAY	CAMDEN	NJ	08103	222764819	501 (C)(3)	$8,500	MEDICAL STUDENT ROTATION AWARDS
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
2500 N STATE ST	JACKSON	MS	39216	646008520	GOV'T UNIT	$8,500	MEDICAL STUDENT ROTATION AWARDS
FLORIDA STATE UNIVERSITY - TALLAHASSEE
282 CHAMPIONS WAY A2201 UCA	TALLAHASSEE	FL	32306	591961248	GOV'T UNIT	$8,500	MEDICAL STUDENT ROTATION AWARDS

Field	Value	IRS element (for citing)
Total501c3 Org	36	Total501c3OrgCnt
Total Other Org	0	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (4 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
GIANNI BONADONNA BREAST CANCER FELLOWSHIP	1	$10,000
MERIT AWARDS	123	$127,500
PATIENT ADVOCATE SCHOLARSHIPS	105	$156,000
ONCOLOGY TRAINEE TRAVEL AWARDS	19	$21,280

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	0	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ALLEN S LICHTER MD FASCO
CEO	$0	$650,820	$0	$74,000	$0	$60,000	$0	$19,125	$0	$830	$0	$804,775	$0	$0
NANCY DALY MS MPH
EXECUTIVE DIRECTOR	$0	$231,000	$0	$0	$0	$0	$0	$17,325	$0	$11,448	$0	$259,773	$0	$0
PAUL AINES CPA
CFO	$0	$312,000	$0	$5,000	$0	$0	$0	$19,125	$0	$16,176	$0	$352,301	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 3	FormAndLineReferenceDesc
Explanation	COMPENSATION IS ESTABLISHED BY A RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. THE METHODS USED BY ASCO TO DETERMINE COMPENSATION ARE: COMPENSATION COMMITTEE; INDEPENDENT COMPENSATION CONSULTANT; FORMS 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT; COMPENSATION STUDY OR SURVEY; AND APPROVAL BY BOARD OR COMPENSATION COMMITTEE.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1	AS OF DECEMBER 31, 2013, THE BOARD OF DIRECTORS OF CCF INCLUDED FOURTEEN (14) DIRECTORS WITH VOTING RIGHTS AND TWO (2) DIRECTORS WITHOUT VOTING RIGHTS. THIRTEEN (13) DIRECTORS WITH VOTING RIGHTS WERE APPOINTED BY THE BOARD OF DIRECTORS OF ASCO, A NON-PROFIT, 501(C)(3) TAX-EXEMPT ORGANIZATION, A RELATED ORGANIZATION. THERE WERE THREE EX-OFFICIO DIRECTORS: THE CHIEF EXECUTIVE OFFICER (CEO) (WITH VOTING RIGHTS), THE ASCO PRESIDENT (WITHOUT VOTING RIGHTS) AND THE EXECUTIVE DIRECTOR (WITHOUT VOTING RIGHTS). ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS CONSISTENT WITH CCF'S BYLAWS. THE EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIR, CEO, SECRETARY, TREASURER, AND A FIFTH EXECUTIVE COMMITTEE MEMBER ELECTED BY THE DIRECTORS. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF CCF'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CCF'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPT AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CCF'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 7A	CCF DOES NOT HAVE MEMBERS. DIRECTORS OF CCF ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO.
FORM 990, PART VI, SECTION A, LINE 7B	THE BOARD OF DIRECTORS OF CCF MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CCF, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE. CCF MAY NOT AMEND ITS ARTICLES OF INCORPORATION WITHOUT PROVIDING TO ASCO WRITTEN NOTICE OF THE PROPOSED AMENDMENT AT LEAST THIRTY (30) DAYS IN ADVANCE.
FORM 990, PART VI, SECTION B, LINE 11	AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE CCF FINANCE COMMITTEE AND WAS DISCUSSED AT A MEETING OF THE FINANCE COMMITTEE BEFORE IT WAS FILED. AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. THE CCF FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE EXECUTIVE DIRECTOR, THE CEO, AND THE GENERAL COUNSEL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	CCF MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER CCF STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS. UNDER CCF'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. CCF'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS.
FORM 990, PART VI, SECTION B, LINE 15	THE FOLLOWING EMPLOYEES OF ASCO SERVE AS OFFICERS OF CCF: CEO OF CCF (ALSO SERVES AS CEO OF ASCO) EXECUTIVE DIRECTOR OF CCF CFO OF CCF (ALSO SERVES AS CFO OF ASCO) GENERAL COUNSEL OF CCF (ALSO SERVES AS VP/GENERAL COUNSEL OF ASCO) INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION ARE DESCRIBED IN THE IRS FORM 990 OF ASCO. CCF STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CCF. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO. CCF DOES NOT PAY COMPENSATION TO THESE INDIVIDUALS.
FORM 990, PART VI, SECTION C, LINE 19	CCF'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. CCF'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CCF'S WEBSITE. THE ANNUAL REPORT OF CCF IS POSTED ON CCF'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS OF CCF ARE POSTED ON CCF'S WEBSITE.
FORM 990, PART XI, LINE 9:	RELINQUISHED AWARDS 252,053.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC	BusinessNameLine1

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
EIN	136180380	EIN
Primary Activities	SUPPORTS CANCER RESEARCH, EDUCATION AND QUALITY IMPROVEMENT PROGRAMS	PrimaryActivitiesTxt
Legal Domicile State	NY	LegalDomicileStateCd
Exempt Code Section	501(C)(3)	ExemptCodeSectionTxt
Public Charity Status	LINE 9	PublicCharityStatusTxt
Direct Controlling NA	N/A	DirectControllingNACd
Controlled Organization	0	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (1)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (1)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	Yes (1)	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	Yes (1)	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	Yes (1)	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (1)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (1)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (1)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (1)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd